35 bytes added ,  15:53, 3 March 2009
Line 10: Line 10:     
Other systems affected by alpha-2 agonists include:
 
Other systems affected by alpha-2 agonists include:
* Cardiovascular System
+
* <u>Cardiovascular System</u>
 
** Post synaptic alpha-2 effects and non-selective action on alpha-1 receptors cause vasoconstriction, hypertension and reflex bradycardia.
 
** Post synaptic alpha-2 effects and non-selective action on alpha-1 receptors cause vasoconstriction, hypertension and reflex bradycardia.
 
** Pre-synaptic inhibition of noradrenaline release gives a reduced sympathetic outflow. This dexreases heart rate and offsets vasoconstriction.  
 
** Pre-synaptic inhibition of noradrenaline release gives a reduced sympathetic outflow. This dexreases heart rate and offsets vasoconstriction.  
* Respiratory System
+
* <u>Respiratory System</u>
 
** The drugs cause mild depression of the respiratory systsem.
 
** The drugs cause mild depression of the respiratory systsem.
 
** The response to hypercapnoea is reduced.
 
** The response to hypercapnoea is reduced.
* Gastrointestinal Tract
+
* <u>Gastrointestinal Tract</u>
 
** Alpha-2 agonists cause extreme vomitting in dogs and cats. [[#Xylazine|Xylazine]] is the worst culprit for this.
 
** Alpha-2 agonists cause extreme vomitting in dogs and cats. [[#Xylazine|Xylazine]] is the worst culprit for this.
 
** Huge reductions in gut motility occur following drug administration, as well as decreased salivation and secretion.
 
** Huge reductions in gut motility occur following drug administration, as well as decreased salivation and secretion.
* Endocrine System
+
* <u>Endocrine System</u>
 
** Alpha-2 agonists inhibit ADH, leading to diuresis.
 
** Alpha-2 agonists inhibit ADH, leading to diuresis.
 
** Insulin is also inhibited, causing hyperglycaemia which leads to osmotic diuresis. This, along with the aboce, causes excessive urination.
 
** Insulin is also inhibited, causing hyperglycaemia which leads to osmotic diuresis. This, along with the aboce, causes excessive urination.
 
** Growth hormone release is triggered by alhpa-2 agonists.
 
** Growth hormone release is triggered by alhpa-2 agonists.
* Urogenital Tract
+
* <u>Urogenital Tract</u>
 
** Uterine contraction occurs with alpha-2 agonist administration.
 
** Uterine contraction occurs with alpha-2 agonist administration.
  
6,502

edits